Trial Sites for Ewing Sarcoma Trial Have Been Expanded in The United States
Salarius Pharmaceuticals has just announced the addition of a new clinical trial site for their study investigating seclidemstat as a treatment for Ewing sarcoma (relapsed or refractory) as well as…